4//SEC Filing
Puche Luisa 4
Accession 0001731122-21-002163
CIK 0001527728other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 7:01 PM ET
Size
8.5 KB
Accession
0001731122-21-002163
Insider Transaction Report
Form 4
Puche Luisa
Chief Financial Officer
Transactions
- Other
Restricted Stock Units
2019-06-09$6.15/sh−15,000$92,250→ 0 totalExercise: $6.15Exp: 2029-06-09→ Common Stock (15,000 underlying) - Award
Restricted Stock Units
2021-12-16$7.75/sh+16,266$126,062→ 16,266 totalExercise: $7.75Exp: 2031-12-16→ Common Stock (16,266 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Enochian Biosciences Inc. common stock.
- [F2]The reporting person received restricted stock units under the Enochian BioSciences Inc. 2019 Equity Incentive Plan. 11,266 of the restricted stock units shall vest on the Grant Date; the remaining 5,000 restricted stock units shall vest on January 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
- [F3]Reflects the decision of the Enochian BioSciences Inc. board of directors to void and rescind, nunc pro tunc, the grant of 15,000 RSUs previously approved on June 9, 2019, under the Issuer's 2019 Equity Incentive Plan. As of the date of this Form 4, 10,000 RSUs had vested; the reporting person has agreed to surrender the 10,000 shares of common stock underlying the RSUs to Enochian BioSciences Inc. for cancellation.
Documents
Issuer
Enochian Biosciences Inc
CIK 0001527728
Entity typeother
Related Parties
1- filerCIK 0001768468
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 7:01 PM ET
- Size
- 8.5 KB